Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MDM4 | O15151 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29356434 | 1.00 | CASP3 (0.60) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29375252 | 1.00 | CASP3 (0.60) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL30307097 | 1.00 | CASP3 (0.60) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL799720 | 1.00 | CASP3 (0.60) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL178791 | 1.00 | CASP3 (0.60) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29423588 | 1.00 | CASP3 (0.60) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL31697682 | 1.00 | CASP3 (0.60) | CASP3KMT2AMDM4TP53EPHX2 | |
| Hydrochloric Acid SCHEMBL6779156 | 0.99 | CASP3 (0.59) | CASP3KMT2AMDM4TP53EPHX2 | |
| Fluoride SCHEMBL7158848 | 0.99 | CASP3 (0.59) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29068310 | 0.95 | CASP3 (0.64) | CASP3KMT2AMDM4TP53EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 775 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119901859-A | Analysis method for purity of fluorenylmethoxycarbonyl-L-valine and related substances | 苏州默迪夫生物科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| US-20240351975-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | XWPharma Ltd. (KY) | 2024-10-24 | — | — | US | claimed |
| CN-117924414-A | Compound for promoting Abeta clearance and preparation method and application thereof | 中山大学 | 2024-04-26 | — | — | CN | claimed |
| CN-114456234-B | Antioxidant lipopeptides, preparation method and application thereof | 中国石油大学(华东) | 2023-06-30 | — | — | CN | claimed |
| CN-114456234-A | Antioxidant lipopeptide and preparation method and application thereof | 中国石油大学(华东) | 2022-05-10 | — | — | CN | claimed |
| EP-3988538-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Zhida Pharmaceutical Co., Ltd. (CN) | 2022-04-27 | — | — | EP | claimed |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | ZHEJIANG ZHIDA PHARMACEUTICAL CO., LTD. (CN) | 2022-04-14 | — | — | US | claimed |
| CN-110054574-B | Synthesis method of fluorenylmethyloxycarbonyl-2, 3-dehydro-valine | 上海吉奉生物科技有限公司 | 2021-08-20 | — | — | CN | claimed |
| WO-2020252713-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | 浙江智达药业有限公司 | 2020-12-24 | — | — | WO | claimed |
| CN-112110834-A | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-108440654-B | Synthesis method of antibacterial active cyclic hexapeptide Thermoactinamide A | 暨南大学 | 2020-09-04 | — | — | CN | claimed |
| CN-108373496-A | Inoxidizability polypeptide GTMGAVGPRG and preparation method thereof | 安徽工程大学 | 2018-08-07 | — | — | CN | claimed |
| CN-103626844-B | Artificially synthesized wheat germ peptide and preparation method and application thereof | CHANGSHA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2015-08-19 | — | — | CN | claimed |
| CN-103626844-A | Artificially synthesized wheat germ peptide and preparation method and application thereof | UNIV CHANGSHA SCIENCE | 2014-03-12 | — | — | CN | claimed |
| EP-4748847-A1 | PEPTIDE COMPLEX HAVING VEGFR -2 AGONIST ACTIVITY | Peptidream Inc (JP) | 2026-05-27 | — | — | EP | disclosed |
| EP-4029868-B1 | MCL-1 INHIBITORS | GILEAD SCIENCES INC (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3972649-B1 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| WO-1989008643-A1 | URETHANE-PROTECTED AMINO ACID-N-CARBOXYANHYDRIDES | BIORESEARCH, INC. (US) | 1989-09-21 | — | — | WO | disclosed |
| EP-0305929-A2 | Membranes with bound oligonucleotides and peptides | MILLIPORE CORPORATION (US) | 1989-03-08 | — | — | EP | disclosed |
| US-4108846-A | FOR PRODUCTION OF POLYPEPTIDES | HOFFMANN-LA ROCHE INC. | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240351975-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | GABBR1, GABBR2, GABRB3 | CASP3 2672/4885KMT2A 2039/4885MDM4 1218/4885 |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | CETP, SLC43A1, SLC27A1 | CASP3 2158/4885KMT2A 2845/4885MDM4 884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.